IMCIVREE FDA approval date

The FDA approved IMCIVREE on 25 Nov 2020.

FDA approval date
25 Nov 2020

Drug identity has not yet been verified against registry records

Also recorded as SETMELANOTIDE ACETATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-11-25DayIMCIVREEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA213793", "applicant_as_listed_by_fda": "RHYTHM", "brand_names": ["IMCIVREE"], "active_ingredients": ["SETMELANOTIDE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20201125", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026